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Abstract
Listeria monocytogenes is a facultative intracellular pathogen capable of inducing a robust cell-mediated immune response
to sub-lethal infection. The capacity of L. monocytogenes to escape from the phagosome and enter the host cell cytosol is
paramount for the induction of long-lived CD8 T cell–mediated protective immunity. Here, we show that the impaired T cell
response to L. monocytogenes confined within a phagosome is not merely a consequence of inefficient antigen
presentation, but is the result of direct suppression of the adaptive response. This suppression limited not only the adaptive
response to vacuole-confined L. monocytogenes, but negated the response to bacteria within the cytosol. Co-infection with
phagosome-confined and cytosolic L. monocytogenes prevented the generation of acquired immunity and limited
expansion of antigen-specific T cells relative to the cytosolic L. monocytogenes strain alone. Bacteria confined to a
phagosome suppressed the production of pro-inflammatory cytokines and led to the rapid MyD88-dependent production
of IL-10. Blockade of the IL-10 receptor or the absence of MyD88 during primary infection restored protective immunity. Our
studies demonstrate that the presence of microbes within a phagosome can directly impact the innate and adaptive
immune response by antagonizing the signaling pathways necessary for inflammation and the generation of protective CD8
T cells.
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Introduction
The intracellular bacterium L. monocytogenes has been studied for
decades as a model of innate and cellular immunity [1]. Infection
with L. monocytogenes leads to a robust innate and adaptive response,
characterized by the generation of long-lived antigen-specific CD4
and CD8 T cells [2], the latter of which are predominantly
responsible for protective immunity [3,4]. Following engulfment
by the host cell, L. monocytogenes escapes from the phagosome and
into the host cell cytosol via secretion of the pore-forming
cytolysin, listeriolysin O (LLO) [5]. Once within the cytosol, the
bacteria express ActA that facilitates cell to cell spread via
polymerization of host-cell actin [6]. ActA-deficient mutants still
induce protective immunity, while mutants lacking LLO (some-
times designated as Dhly) elicit an antigen-specific T cell response,
but these T cells are unable to provide protective immunity [7,8].
Escape of L. monocytogenes into the cytosol permits bacterial growth
and facilitates the MyD88-independent activation of a cytosolic
surveillance pathway, leading to the production of a unique array
of cytokines, including type I IFN [9–12]. What remains unclear is
why L. monocytogenes, which contains ligands for multiple Toll-like
receptors found on the cell surface and within the phagosome, only
elicits effective adaptive immunity when entering the host cell
cytosol [13,14].
Innate immune recognition of L. monocytogenes is critical for
controlling early microbial replication [2]. Interaction of the
bacterium with host pattern recognition receptors (PRR) triggers a
cascade of cytokines and chemokines that both recruits and arms
innate immune effectors [15,16]. L. monocytogenes contains ligands
for TLR2 (peptidoglycan, lipotechoic acid and lipoproteins),
TLR5 (flagellin), TLR9 (CpG motifs), and NOD2 (muramyl
dipeptide), all of which may elicit proinflammatory cytokine
secretion [17–22]. Rapid secretion of chemokines such as MCP-1
and MCP-3, and cytokines such as IFN-c and TNF are essential
for enhancing the recruitment and bacteriocidal functions of
macrophages and neutrophils, which act to restrict bacterial
burden prior to the onset of the adaptive response [23–25].
Typically suppressive cytokines such as IL-10 are also elicited in
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response to L. monocytogenes infection where they may contribute to
bacterial persistence as well as T cell potency [26–28]. The innate
response to these PRR-ligands also serves to shape the ensuing
adaptive immune response [29]. Innate inflammatory cytokines
produced in response to L. monocytogenes infection facilitate
dendritic cell (DC) maturation and migration to the infection-
associated secondary lymphatics [29,30]. Maturation is essential
for enhancing the stimulatory capacity of the DC via upregulation
of costimulatory surface molecules and cytokines (e.g. CD80/86,
CD70, IL-12p70, IL-18, IFN-a/b) [31]. Maturation also facilitates
migration of the DC into the draining lymph node where it can
interact with large numbers of naı¨ve T cells [32]. Together, the
local cytokine milieu and dendritic cell maturation state signifi-
cantly contribute to the outcome of the DC-T cell interaction and
ultimately, the potency of the T cell response [33].
We questioned how the response to a bacterium confined within
a phagosome would impact the adaptive response to a bacterium
within the host cell cytosol. Mice were infected with two distinct
strains of L. monocytogenes. The first strain, ActA-Lm, escapes into
the host cell cytosol and elicits long-lived CD8 T cell-dependent
protective immunity [23,34]. Because it cannot spread between
cells, ActA-Lm is highly attenuated in vivo, can be administered at
a higher dose, and is rapidly cleared from both liver and spleen
(relative to wild-type L. monocytogenes). A second strain, LLO-Lm, is
unable to produce listeriolysin O (LLO), and thus cannot escape
from the phagosome [35]. Importantly, infection with LLO-Lm
elicits CD8 T cells, but little or no protective immunity to a lethal
wild-type L. monocytogenes challenge [7,8]. To facilitate enumer-
ation of L. monocytogenes-specific CD8 and CD4 T cell responses
following infection, we used strains expressing chicken ovalbumin
(OVA) fused to a non-lytic fragment of LLO.
Results
Phagosome-confined L. monocytogenes negatively
impact protective immunity
To better understand the impact of phagosome-confined
bacteria on the adaptive immune response we infected cohorts
of mice with an identical dose of ActA-Lm-OVA (16105 colony
forming units (CFU)), a dose sufficient to elicit long-lived CD8 T
cell-mediated protective immunity. To this inoculum, we added
increasing numbers of phagosome-confined LLO-Lm-OVA. We
assessed protective immunity 60 days later by challenging with
wild-type-L. monocytogenes-OVA, and then enumerating CFU in the
spleen (Figure 1A). Strikingly, the protective immunity typically
elicited by ActA-Lm-OVA was compromised by the presence of
phagosome-confined LLO-Lm-OVA during primary infection. In
other words, despite a significant increase in antigen during
primary infection, the adaptive response to the cytosolic bacterium
was impaired by the presence of bacteria within a phagosome. A
potential explanation for this finding was that the addition of
LLO-Lm-OVA to the inoculum facilitated more rapid clearance
of ActA-Lm-OVA, decreasing the duration of antigen presentation
and negatively impacting T cell potency. To test this hypothesis,
we used an erythromycin-resistant strain of ActA-Lm (ActA-Lm-
ErmR) combined with a large number of LLO-Lm (16108 CFU).
We followed the clearance of the ActA-Lm-ErmR strain by
enumerating CFU on agar containing erythromycin (Figure 1B, C
and D). Importantly, the addition of LLO-Lm did not impact the
rate at which ActA-Lm-ErmR were cleared from the spleen or liver
or the in vitro growth rate within bone marrow-derived
macrophages.
To determine whether the phagosome-confined bacteria
required metabolic activity, heat-killed L. monocytogenes were added
to an inoculum of ActA-Lm (Figure 1E). Similar to our
observations with LLO-Lm, the addition of HK-L. monocytogenes
also limited protective immunity. In a similar fashion, the addition
of the unrelated phagosome-confined non-pathogenic bacterium
Bacillus subtilis also attenuated protective immunity (Figure 1F).
Finally, the addition of LLO-Lm-OVA to an inoculum of wt-L.
monocytogenes also impaired protective immunity (Figure 1G).
Similar observations were made during experiments utilizing
Balb/c mice (data not shown). Thus, as few as 96105 CFU of
phagosome-confined LLO-Lm-OVA added to an inoculum of
cytosolic ActA-Lm-OVA during primary infection leads to a
greater than 1000-fold increase in CFU following wild-type
challenge.
Phagosome-confined L. monocytogenes negatively
impact the magnitude of the primary CD4 and CD8 T cell
response
Given the role of CD8 T cells in protective immunity, we
questioned how the addition of increasing numbers phagosome-
confined LLO-Lm-OVA would impact the primary T cell
response to a constant dose of ActA-Lm-OVA. Similar to our
observations following wild-type L. monocytogenes challenge, the 10
to 1000-fold increase in the number of OVA-expressing bacteria
did not improve the primary T cell response. Instead, the
magnitude of the primary CD8 OVA257–264 and CD4 LLO190–
201–specific response declined as the ratio of phagosome-confined
to cytosolic bacteria increased (Figure 2). The frequency of
OVA257–264-specific CD8+ T cells determined by IFN-c staining
was confirmed using Kb-OVA257–264 multimers to rule out the
existence of OVA257–264 -specific CD8+ T cells incapable of
producing IFN-c. To understand if suppression of the T cell
response was antigen specific, we performed similar studies using
LLO-Lm that did not express OVA (Figure 3A). These studies
demonstrated that suppression was antigen-independent, as LLO-
Lm expresses neither the OVA257–264 nor the LLO190–201
epitopes. Furthermore, the reduced magnitude of the primary
response was independent of the class I-restricting allele or the
affinity of the MHC-peptide interaction as observed using L.
monocytogenes strains expressing four defined vaccinia virus-derived
Author Summary
Little is understood about how the immune system
distinguishes between pathogenic and non-pathogenic
microbes. Limiting or preventing infections by intracellular
pathogens requires the activation of innate immunity and
the consequent generation of effector and memory T cells,
which recognize and kill infected cells. Investigators are
currently testing attenuated versions of pathogenic
microbes as vaccines in an attempt to generate patho-
gen-specific T cells without causing disease. Unfortunately,
attenuated microbes often fail to elicit long-lived protec-
tive immunity. We hypothesized that attenuated bacterial
vaccines do not immunize because they fail to activate a
stimulatory arm of host innate immune receptors.
However, we found that these attenuated bacterial
vaccines are not simply prevented from activating
immunity, but rather generate a negative signal that
inhibits the desired immune response. These studies may
explain why the addition of an adjuvant to ineffective
vaccines does not necessarily improve immunogenicity.
Furthermore, these studies provide a framework for the
development of attenuated vaccines that do not inhibit
the desired immune responses.
Bacterial Suppression of Cell-Mediated Immunity
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Figure 1. L. monocytogenes within a phagosome impairs protective immunity. Mice were infected with 16105 CFU ActA-Lm–OVA alone, or
in combination with increasing doses of phagosome-confined LLO-Lm-OVA. (A) Mice were challenged 60 days later with a lethal dose of wt L.
monocytogenes-OVA. Spleens were harvested 3 days later and CFU per spleen determined. (B) Mice were infected with 16105 CFU ActA-Lm-ErmR
alone, or in combination with 16108 CFU LLO-Lm. Erythromycin-resistant colonies were enumerated from the spleen and liver over 96 hours. Each
data point represents the mean and standard error of 5 mice per group. (C) Mice were infected with 16105 CFU ActA-Lm-ErmR alone, or in
combination with 16108 CFU LLO-Lm. Erythromycin-resistant colonies were enumerated from the spleen and liver at 1 and 6 hours post infection.
Each data point represents the mean and standard error of 5 mice per group from one representative experiment of two. (D) Bone marrow-derived
macrophages were infected with ActA-Lm-ErmR alone (at 1:10,000), or in combination with 16108 CFU LLO-Lm (at 1:200). Erythromycin-resistant
colonies were enumerated at the indicated timepoints. Each data point represents the mean and standard error of 3 independent coverslips per
timepoint from one representative experiment of two. (E) Mice were infected with the indicated combinations of 16105 CFU ActA-Lm–OVA and
16108 heat-killed ActA-Lm–OVA. 30 days later, mice were challenged with 16105 CFU of wt L. monocytogenes-OVA. Spleens were harvested 3 days
later and CFU per spleen determined. (F) Mice were infected with 16105 CFU ActA-Lm, 16105 CFU B. subtilis, or the combination of both strains. 30
days post infection, mice were challenged and CFU determined. (G) Mice were infected with the indicated combinations of 16103 CFU wild-type and
16106 CFU LLO-Lm. 58 days later, mice were challenged with 16105 CFU of wild-type L. monocytognes. Spleens were harvested 3 days later and CFU
per spleen determined. In all panels, each point represents a single animal with { indicating animals that died before CFU were determined. Lines
indicate the median of each group.
doi:10.1371/journal.ppat.1000568.g001
Bacterial Suppression of Cell-Mediated Immunity
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epitopes (Figure 3B) [36]. Therefore, the presence of LLO-Lm
within a phagosome negatively impacts both the primary CD4 and
CD8 T cell response to cytosolic ActA-Lm as well as protective
immunity.
Phagosome-confined L. monocytogenes limit
inflammatory cytokine production
The innate immune response during infection plays a critical
role in shaping the ensuing adaptive response. Based on the
observed suppression of CD4 and CD8 T cell responses, we
hypothesized that the presence of phagosome-confined L.
monocytogenes altered the inflammatory cytokine response to the
cytosolic ActA-Lm strain. We compared serum cytokines between
mice infected with ActA-Lm-OVA alone versus in combination
with increasing numbers of LLO-Lm-OVA. Infection with
combinations of LLO-Lm-OVA and ActA-Lm-OVA led to the
dose-dependent reduction of serum IFN-c, IL-12p70, IL-6 and
MCP-1 relative to ActA-Lm-OVA alone (Figure 4A). Thus, LLO-
Lm-OVA bacteria within a phagosome exert a negative effect on
the pro-inflammatory response elicited by ActA-Lm-OVA within
the cytosol. Because many vacuolar pathogens elicit a Th2-type
cytokine profile [37], we questioned the ability of LLO-Lm-OVA
to elicit cytokines that might limit the potency of the adaptive T
cell response. Four hours post infection, serum IL-10 was
detectable in mice immunized with LLO-Lm-OVA, either alone
or in combination with ActA-Lm-OVA, and required the adapter
protein MyD88 (Figure 4B). In addition, we detected high levels of
IL-12p40 in the absence of heterodimeric IL-12p70, suggesting
high levels of IL-12p40 homodimer were present in the serum
(although we cannot rule out that p40 was complexed with p19 as
functional IL-23). Thus, the addition of phagosome-confined
LLO-Lm-OVA to an inoculum of ActA-Lm-OVA inhibits
inflammatory cytokine production and corresponds with elevated
levels of IL-10.
Suppression of protective immunity by phagosome-
confined L. monocytogenes is dependent on MyD88 and
IL-10R signalling
To examine the role of IL-10 in limiting the potency of the
adaptive response to LLO-Lm-OVA, mice were infected with
ActA-Lm-OVA and LLO-Lm-OVA in combination with an
antagonist IL-10 receptor antibody (anti-IL-10R) [38]. This
regimen permits blockade of IL-10 signalling during priming
while maintaining an intact immune system during challenge.
Only the highest dose of LLO-Lm-OVA was used in combination
with ActA-Lm-OVA, a combination that led to the greatest
Figure 2. L. monocytogenes within a phagosome impairs the primary T cell response. Mice were infected with 16105 CFU ActA-Lm–OVA
alone, or in combination with increasing doses of LLO-Lm-OVA. 7 days later, the frequency of OVA257–264-specific CD8 T cells and LLO190–201-specific
CD4 T cells was determined by pentamer and IFN-c intracellular cytokine staining. Total splenocyte number and absolute CD8 T cells per spleen were
consistent between all groups. Values in each plot represent the mean6SEM of antigen-specific cells within the CD4 or CD8 population from 5
animals per group.
doi:10.1371/journal.ppat.1000568.g002
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Figure 3. Suppression of the primary T cell response is antigen-independent. (A) Mice were infected with the indicated combinations of
16105 CFU ActA-Lm, 16105 CFU ActA-Lm–OVA, 16108 CFU LLO-Lm, and 16108 CFU LLO-Lm-OVA. 7 days later, the frequency of OVA257–264 -specific
CD8 and LLO190–201 -specific CD4 T cells was determined by IFN-c intracellular cytokine staining. (B) ActA-Lm and LLO-Lm L. monocytogenes were
engineered to express 4 defined epitopes from vaccinia virus. Mice were infected intravenously with the indicated combinations of ActA-Lm-
QuadVacc and LLO-Lm-QuadVacc. 7 days later, spleens were harvested and the frequency of CD8 T cells specific for each epitope was determined by
IFN-c intracellular cytokine staining. Total splenocyte number and absolute CD8 T cells per spleen were consistent between all groups. Values in each
plot represent the mean6SEM of IFN-c+ cells within the CD4 or CD8 population from 5 animals per group.
doi:10.1371/journal.ppat.1000568.g003
Bacterial Suppression of Cell-Mediated Immunity
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suppression of inflammatory cytokines and protective immunity
(Figures 1–4). On day 30, mice were challenged with wild-type-L.
monocytogenes-OVA and protective immunity assessed 3 days later.
Impressively, mice co-infected with LLO-Lm-OVA and ActA-Lm-
OVA in the presence of IL-10R blockade demonstrated equivalent
protection against wt-L. monocytogenes-OVA challenge as anti-IL-
10R treated mice infected with ActA-Lm-OVA alone (Figure 5A).
IL-10 production following LLO-Lm infection was MyD88-
dependent; therefore we questioned whether LLO-Lm would limit
ActA-Lm-induced protective immunity in mice lacking MyD88.
Similar to the results following IL-10R blockade, MyD882/
2mice immunized with the combination of ActA-Lm-OVA and
LLO-Lm-OVA were protected against a lethal challenge with wt
L. monocytogenes (Figure 5B). Thus, in the absence of MyD88
signalling, the ability of phagosome-confined L. monocytogenes to
limit the adaptive response to L. monocytogenes within the cytosol is
eliminated. Together, these results demonstrate that the innate
immune system discriminates between pathogens that reside in
Figure 4. L. monocytogenes within a phagosome suppress the host inflammatory response to bacteria within the cytosol. (A) Mice
were infected with 16105 CFU ActA-Lm–OVA alone, or in combination with increasing doses of LLO-Lm-OVA. Serum was collected 24 hours later and
assayed for IFN-c, IL-12p70, IL-6, and MCP-1. (B) C57Bl/6 and B6.MyD882/2 mice were infected with 16105 CFU ActA-Lm–OVA, 16108 CFU LLO-Lm-
OVA, or the combination of both strains. Serum was collected 4 hours later and assayed for IL-10 and IL-12p40. Bars represent the mean and standard
error of 5 mice per group.
doi:10.1371/journal.ppat.1000568.g004
Bacterial Suppression of Cell-Mediated Immunity
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distinct subcellular locations, and via a MyD88- and IL-10-
dependent mechanism, impacts the potency of the adaptive
immune response.
Discussion
How the immune system differentiates between pathogenic and
non-pathogenic microbes and translates this information into an
appropriate immune response is not completely understood.
Previous reports have shown that intracellular bacteria, including
L. monocytogenes, activate a unique host cytosolic surveillance pathway
of innate immunity while extracellular bacteria do not [9,16,39,40].
These studies led to our original hypothesis that activation of the
host cytosolic surveillance pathway provided an explanation to the
observations that heat-killed and LLO- L. monocytogenes fail to
immunize mice to subsequent challenge [8,41]. Our original goal in
these studies was to improve the potency of CD8 T cells responding
to phagosome-confined LLO-Lm-OVA by complementing it with a
cytosolic L. monocytogenes strain. Surprisingly, we found that the
presence of phagosome-confined LLO-Lm negated the innate
response to the cytosolic L. monocytogenes strain and ultimately
compromised long-lived protective immunity (Figure 1). These
results suggest that although recognition of microbial constituents
within the cytosol may elicit cytokines that improve the cellular
immune response, it is the exit from the phagosome that permits this
inflammatory response to take place.
Our data indicate that the potency of the adaptive T cell
response is incrementally altered as the ratio of intracellular to
phagosome-confined bacteria changes. Both ActA-Lm and LLO-
Lm are similarly distributed amongst phagocytic cells in vivo [42].
Furthermore, because ActA-Lm cannot polymerize host-cell actin,
neither strain will spread into neighbouring cells [43]. Thus the
ratio of ActA-Lm to LLO-Lm will not alter the cell types that
interact with the bacteria. To avoid overwhelming the innate
immune system with L. monocytogenes, we decreased the dose of
ActA-Lm to 16105 CFU (from the standard 0.16LD50 dose of
16107 CFU) then added 10–1000-fold of LLO-Lm to the
inoculum. Using these doses, the input CFU exceeded 16107
CFU in only the highest dose group (16105 CFU ActA-
Lm+16108 CFU LLO-Lm). Therefore, the loss of protective
immunity observed following infection with 16106 and 16107
total CFU could not be explained by the increase in total CFU
alone, as 16107 CFU of ActA-Lm has been shown many times to
elicit complete protective immunity to wild-type challenge [34,44].
The innate response to infection plays a pivotal role in shaping
the adaptive immune response [29]. Suppression of cytokines and
chemokines following recognition of microbial PRRs could impact
the adaptive response via multiple mechanisms [45]. Chemokines
produced at the site of infection facilitate the infiltration of
neutrophils, macrophages and dendritic cells to the affected tissues
[3,25]. Neutrophils and activated macrophages are critical for
controlling bacterial replication, while dendritic cells are required
Figure 5. IL-10 receptor blockade during T cell priming prevents the suppressive effects of L. monocytogenes within a phagosome.
Mice were infected with ActA-Lm–OVA, LLO-Lm-OVA, or the combination of both strains in combination with aIL-10R antibody. (A) 30 days post
infection mice were challenged with a lethal dose of wt L. monocytogenes-OVA. Spleens were harvested 3 days later and CFU per spleen determined.
Each bar represents the mean and standard error of 5 mice per group. (B) B6.MyD882/2 mice were infected with 16105 CFU ActA-Lm-OVA, 16108
CFU LLO-Lm-OVA, or the combination of both strains. 16 weeks later, mice were challenged with 16103 CFU wt L. monocytogenes-OVA. Spleens and
livers were harvested 3 days later and CFU per organ determined. Each bar represents the mean and standard error of 3–5 mice per group. Data are
from one representative experiment of two.
doi:10.1371/journal.ppat.1000568.g005
Bacterial Suppression of Cell-Mediated Immunity
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for processing and presentation of microbial peptides [46].
Dendritic cells presenting bacterial antigens undergo maturation
in response to proinflammatory cytokines. This maturation step is
critical for modifying many aspects of dendritic cell function,
including: the expression of specific proteasome subunits and thus,
the repertoire of peptides available for presentation [47,48]; the
density of MHC and co-stimulatory molecules on the cell surface
[49]; and secretion of chemoattractants which recruit naı¨ve T cells
into the secondary lymphatics. In addition, inflammatory
cytokines can act via direct co-stimulation of T cells during
priming [50]. Thus, by virtue of its inability to escape from the
phagosome, LLO-Lm alters the innate inflammatory landscape
and ultimately, the potency of the Listeria-specific T cell response.
The impact of cytokines on T cell potency is complex, as the
effect of a specific cytokine can be dependent on location, context,
and concentration. In previous studies, IL-10 was necessary for
optimal T cell memory following L. monocytogenes infection [28].
However, elimination of IL-10 signalling from only CD8 T cells
improved the magnitude and function of the response [26]. In
agreement, when mice were immunized with ActA-Lm during IL-
10R blockade, a small but reproducible increase in liver and
spleen cfu was observed after wild-type challenge (Figure 5A).
Conversely, when the IL-10 receptor was blocked during
immunization with LLO-Lm-OVA, protective immunity im-
proved, resulting in 2–3 logs fewer CFU following lethal challenge.
While IL-10 was detectable in low, but reproducible amounts
following immunization with LLO-Lm-OVA, we were unable to
measure IL-10 following immunization with ActA-Lm (Figure 3B).
Furthermore, serum IL-10 was only consistently detectable using
the highest dose of LLO-Lm, 16108 CFU. Measuring serum IL-
10 in the presence of IL-10R blockade prevents IL-10 uptake and
greatly improves the sensitivity of this assay. This approach
increased serum IL-10 following LLO-Lm-OVA immunization 5–
10-fold, while IL-10 in ActA-Lm immunized mice remained
undetectable (data not shown). Thus, while IL-10 certainly impacts
T cell potency following infection with wild-type- or ActA-Lm, its
concentration is far below that measured after immunization with
LLO-Lm-OVA. When assessing the role of IL-10R signalling on
the suppression of memory T cell function, we chose to use the
highest dose of LLO-Lm (16108 CFU) in combination with 16105
CFU ActA-Lm. This dose combination, which provided the most
consistent levels of serum IL-10, also provided the greatest amount
of suppression (Fig 1–3). Thus, while we demonstrated suppression
of the T cell response by a 1000-fold range of LLO-Lm, the
highest and most inhibitory dose was chosen to assess the
dependence on IL-10R signalling. The biological activity of these
low concentrations of IL-10 suggest that its effects are locally
restricted, requiring only minute concentrations but within a
defined location. One possibility is that as the concentration of
systemic IL-10 increases, its impact on the T cell response changes
from positive to negative regulator. This functional switch might
be attributed to differences in sensitivity to IL-10, or other
cytokines produced within the same microenvironment. These
studies suggest that during L. monocytogenes infection, IL-10 acts as a
negative regulator of T cell potency in CD8 T cells, while acting as
a positive regulator of cellular immunity via its effects on other cell
types.
The results from these studies are significant both to the fields of
microbial pathogenesis and vaccinology. Understanding how
microbes interact with the innate and adaptive immune system
is critical for controlling their pathogenic effects. Vaccines remain
one of the most cost-effective tools for preventing disease and
improving health worldwide. While vaccines that elicit humoral
immunity have been relatively straightforward to develop, vaccines
intended to elicit robust cellular immunity, such as those needed to
combat HIV and tuberculosis, have remained elusive [51]. These
difficulties may be in part due to our poor understanding of how
the adaptive immune response is regulated [52]. Modern
approaches to developing these vaccines have used killed or
attenuated forms of otherwise pathogenic organisms in hopes of
eliciting the appropriate immune response without overt disease
[53]. Upon observing an inadequate immune response, a common
next step is to add an adjuvant to the vaccine to improve its
immunogenicity, or to explain its impotence as a lack of positive
inflammatory signals [54]. Our studies show that recognition of
microbial products within defined cellular compartments can
negate inflammation and limit the potency of the cellular immune
response even when numerous proinflammatory signals are
present. This result may explain why the addition of adjuvants
to safe but ineffective vaccines intended to elicit cellular immunity
is often unsuccessful. Furthermore, these studies add to the
emerging field of microbial subversion of innate and cellular
immunity and serve as a primer for defining new regulatory
signalling pathways [55].
These studies shed new light on the classic observation that only
microbes entering the host cell cytosol lead to a productive
antigen-specific CD8 T cell response. It is not simply a case of
inefficient antigen processing and presentation or the inability to
activate the cytosolic surveillance pathway; the innate immune
response to bacteria residing within a phagosome negates the
innate and adaptive response to otherwise stimulatory bacterial
products. Additional experiments are required to define the exact
receptor-ligand interactions that take place within a phagosome, as
well as to identify other cytokines and chemokines that may impact
inflammation and T cell potency in this scenario. Understanding
these negative regulatory pathways will be pivotal for the rational
design of safe and potent vaccines that elicit long-lived T cell-
mediated immunity.
Methods
Ethics statement
All animal protocols were approved by the Earle A. Chiles
Research Institute, University of California, Berkeley or the Anza
Institutional Animal Care and Use Committee.
Mice, bacterial strains and infections
6–10 week old C57Bl/6 mice were purchased from Charles
River Laboratories (Wilmington, MA). B6.MyD882/2mice were
bred at our facilities. L. monocytogenes strains ActA-Lm-OVA and
LLO-Lm-OVA were constructed as previously described [8]. Both
strains secrete full-length chicken ovalbumin fused to the first 441
amino acids of LLO and controlled by the hly promoter. ActA-Lm-
QuadVacc and LLO-Lm-QuadVacc were constructed using an
ActAN100 fusion with the vaccinia virus derived epitopes
B8R20–27 TSYKFESV K
b-restricted; C4L125–132 LNFRFENV
Kb-restricted; A42R88–96 YAPVSPIVI D
b-restricted; K3L6–15
YSLPNAGDVI Db-restricted [36,56]. Bacteria were grown to
midlog in brain-heart infusion broth, washed in PBS, then injected
intravenously in 200 mL total volume. Mice were injected
intravenously with 250 mg anti-IL-10R (CD210, clone 1B1.3a,
BD Bioscience, San Diego, CA) 2 hours before L. monocytogenes
infection.
Lethal challenge and bacterial enumeration
Mice infected 30 or 60 days prior were challenged with 26LD50
(16105 CFU) wild-type L. monocytogenes-OVA (L4056-OVA). 3
days later, spleens and livers were homogenized and serial
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dilutions plated on BHI-strep agar plates for enumeration.
Experiments using ActA-Lm-ErmR were plated in duplicate using
BHI-strep and BHI-strep-erm agar. In vitro growth was
determined in bone-marrow derived macrophages adhered to
coverslips at the indicated timepoints. Coverslips were vortexed in
lysis buffer and plated on strep-erm agar to enumerate ActA-Lm-
ErmR bacteria.
Flow cytometry
Spleens were harvested, dissociated, and red blood cells
removed by ammonium chloride lysis buffer (Sigma, St. Louis,
MO). Following 5 hours of restimulation with the relevant peptide
in the presence of brefeldin A, cells were stained with anti-CD4
(clone GK1.5 , eBioscience, San Diego, CA) and anti-CD8 (clone
53-6.7, BD Biosciences), then fixed, permeabilized and stained for
intracellular IFN-c. (clone XMG1.2, eBioscience) [8]. Pentamer
staining was performed using Kb-OVA257–264 pentamers conju-
gated to APC (ProImmune Ltd, Bradenton, FL). Data was
acquired on a FACSCanto flow cytometer (BD Bioscience) and
analyzed using FlowJo software (Treestar, Ashland, OR).
Serum cytokines
Serum was analyzed using the CBA Mouse Inflammation Kit
(BD Biosciences) and FACSCanto flow cytometer (IL-10, IFN-c,
MCP-1, IL-6, IL-12p70), and the LincoPlex Multiplex Assay
(Millipore, Billerica, MA) and Luminex 100 instrument (IL-
12p40). Time points of 4 and 24 hours post infection were chosen
as the peaks of the early and late cytokine response, determined
during a kinetic analysis of cytokine production [57].
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